No company or person should be made to feel sorry they pursued a new udea or product. The idea to use an existing product as a platform for a new one allows for a solid jumping off point. If it works or not is yet to be determined. But if it was never pursued, well, we know what that means. There would be zero possibility of working.
Success with Genviro would provide immediate name recognition for DECN as well as financial footing. This would allow DECN to adequately fund the promotion the array of diabetic test strip products that have been developed.
And of course, when speaking of DECN KB is the nucleus of the company.
(0)
(0)
Decision Diagnostics Corp (DECN) Stock Research Links